Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Home - The Pharma Times | Pharma & Health Care News Portal
Tuesday, April 16, 2024

Biotechnology

IT & Software Support

Appointments

IML Names Sunder Rajan As Its Chief Executive Officer

Mumbai, July 01, 2019: Institute of Medicine and Law (IML - a business division of Corporate Law Academy Private Limited) has announced today that its...

Awards

Financial Results

Hester Biosciences Ltd reports Net Profit of Rs. 3.56 crore and Revenues from Operations of Rs. 50.7 crore in Q1FY23

Ahmedabad, August 11, 2022: One of India's leading poultry and animal vaccine manufacturing company, Hester Biosciences Limited has...

Lincoln Pharmaceuticals Ltd reports 28.33% rise in the Standalone Net Profit at Rs.11.85 crore in Q4 FY21

Company recommends dividend of 15% - Rs. 1.5 per share for FY 21 Net Revenues...

Approvals

Sputnik V vaccine granted full permanent approval in Russia

Highest safety and efficacy of Sputnik V confirmed during clinical trials and in real-world use in more than 60 countries around the world Sputnik V...

Clinical Trails

Phase III DECISION Trial of Nexavar® (sorafenib) Meets Primary Endpoint of Improving Progression-Free Survival...

Berlin, January 3, 2013 – Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced that a Phase III trial of Nexavar® (sorafenib) tablets in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory differentiated thyroid cancer has met its primary endpoint of a statistically significant improvement in progression-free survival. The study, called DECISION, evaluated the efficacy and safety of Nexavar compared to placebo. The safety and tolerability were generally consistent with the known profile of Nexavar. Detailed efficacy and safety analysis from this study are expected to be presented at an upcoming medical meeting. Effective treatment options are urgently needed for patients with RAI-refractory differentiated thyroid cancer,” said Dimitris Voliotis, MD, Vice President, Global Clinical Development Oncology, Bayer HealthCare. “We are pleased that the results of this study demonstrate that Nexavar may provide a treatment option for these patients.

Bulk Drug

Health Care

Alternative Medicine

Eye Care

Don’t ignore your eye health during the COVID time

By Dr Somasheila Murthy Head, Cornea and Anterior Segment Service L V Prasad Eye Institute, Hyderabad. The COVID 19 pandemic is here to stay for a...

Sankara Eye Hospital provides AI Driven Smart Vision Glasses Free of Cost to 25...

Bengaluru, October 14, 2023: In a remarkable and heart-warming event, Sankara Eye Hospital, a leading institution in eye care enabled AI driven smart glasses to...

Product News

A Biological solution for Poultry Production

Goa, July 15, 2019 : Professor Jarosław Dastych is the Founder, CEO and President of the Board of Proteon Pharmaceuticals S.A., an innovative biotechnology...

Media Partners

Spotlight

Investments

Packaging

Latest News

Artemis Hospitals Joins the Global Effort to Raise Awareness and Take Action Against Cancer...

Gurgaon, February 07, 2023: Today Marks World Cancer Day, a global effort to raise awareness about cancer and the impact it has on people's lives....

IKRIS Pharma’s Breast Cancer awareness campaign culminates with a Final Run in Noida

• IKRIS Pharma conducted its Final Run today as part of the campaign to promote breast cancer awareness in the country • The  event was...

Dental Care

Hospital Management

Drug Discovery & Development

Developments in Bio-informatics will help drive discoveries

    • Training,  revamp  of  University  system,  Promote  Translation  of  Academicre search, Promoting Bio-Entrepreneurship will accelerate the industry growth

 

  • Synthetic  Biotechnology  has  tremendous  potential,  affordable  gene  sequencing can play a major role in the Food, Energy, fragrance & Flavors

Suppliers

Technology

Companies

Glenfiddich to showcase Experimental Series in collaboration with The Dram Club...

An evening dedicated to pushing the boundaries of whisky with Glenfiddich’s unique Experimental series  Mumbai, July 11, 2019: With thevision to constantly experiment with the...

About 22.5 lakh cancer cases recorded every year

Mumbai, March 28, 2019: As per research done by NICPR the estimated number of people living with the disease is around 22.5...

Marketing

Our Partners

Machinery & Equipments